glycotide semaglutide Oral Semaglutide, the First Ingestible Glucagon-Like Peptide-1 Receptor Agonist: Could It Be a Magic Bullet for Type 2 Diabetes? Semaglutide (Ozempic, Wegovy, Rybelsus) -

The SUSTAIN-6 trial and LEADER trial demonstrated reductions in major adverse cardiovascular events in patients taking semaglutide, regardless of diabetes status

Similar reductions in serum LH were reported with GLP-1/GIP administration, while GLP-1/E treatment restored estrous cyclicity and increased the number of corpora lutea across multiple generations (Sanchez-Garrido et al., 2024)

GLP-1RAs improve metabolic health and this can be particularly helpful in bipolar disorder as patients often have a higher risk of metabolic syndrome

Semaglutide and tirzepatide are both GLP-1 receptor agonists

This doesn't necessarily mean they're unsafeit means you may need to plan ahead or adjust dosing schedules with guidance from your healthcare provider or pharmacist

That somewhere else is often muscle